Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Common Equity (2016 - 2025)

Historic Common Equity for Nephros (NEPH) over the last 17 years, with Q3 2025 value amounting to $10.0 million.

  • Nephros' Common Equity rose 2241.25% to $10.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.0 million, marking a year-over-year increase of 2241.25%. This contributed to the annual value of $8.6 million for FY2024, which is 271.6% up from last year.
  • Latest data reveals that Nephros reported Common Equity of $10.0 million as of Q3 2025, which was up 2241.25% from $9.6 million recorded in Q2 2025.
  • In the past 5 years, Nephros' Common Equity ranged from a high of $15.5 million in Q1 2021 and a low of $7.9 million during Q2 2024
  • Over the past 5 years, Nephros' median Common Equity value was $9.3 million (recorded in 2025), while the average stood at $10.6 million.
  • Per our database at Business Quant, Nephros' Common Equity skyrocketed by 3400.35% in 2021 and then crashed by 3978.57% in 2022.
  • Over the past 5 years, Nephros' Common Equity (Quarter) stood at $14.7 million in 2021, then crashed by 39.79% to $8.9 million in 2022, then decreased by 5.89% to $8.4 million in 2023, then increased by 2.72% to $8.6 million in 2024, then grew by 16.55% to $10.0 million in 2025.
  • Its Common Equity was $10.0 million in Q3 2025, compared to $9.6 million in Q2 2025 and $9.3 million in Q1 2025.